Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.
Hooks SB, Callihan P, Altman MK, Hurst JH, Ali MW, Murph MM
(2010) Mol Cancer 9
: 289MeSH Terms: Antineoplastic Agents, Cell Line, Tumor, Cell Survival, Cisplatin, Computational Biology, Docetaxel, Drug Resistance, Neoplasm, Female, Humans, Lysophospholipids, Ovarian Neoplasms, Polymerase Chain Reaction, RGS Proteins, Signal Transduction, Taxoids, VincristineAdded September 20, 2016
16 MeSH Terms
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.
Bauer JA, Chakravarthy AB, Rosenbluth JM, Mi D, Seeley EH, De Matos Granja-Ingram N, Olivares MG, Kelley MC, Mayer IA, Meszoely IM, Means-Powell JA, Johnson KN, Tsai CJ, Ayers GD, Sanders ME, Schneider RJ, Formenti SC, Caprioli RM, Pietenpol JA
(2010) Clin Cancer Res 16
: 681-90MeSH Terms: Biomarkers, Pharmacological, Breast Neoplasms, Carcinoma, Combined Modality Therapy, Drug Resistance, Neoplasm, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Genomics, Humans, Metabolome, Neoadjuvant Therapy, Oligonucleotide Array Sequence Analysis, Paclitaxel, Proteomics, Taxoids, Tumor Cells, CulturedAdded November 13, 2013
17 MeSH Terms
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.
Kim WY, Whang YE, Pruthi RS, Baggstrom MQ, Rathmell WK, Rosenman JG, Wallen EM, Goyal LK, Grigson G, Watkins C, Godley PA
(2011) Urol Oncol 29
: 608-13MeSH Terms: Adenocarcinoma, Aged, Antineoplastic Combined Chemotherapy Protocols, Disease Progression, Disease-Free Survival, Docetaxel, Estramustine, Humans, Male, Middle Aged, Neoadjuvant Therapy, Neoplasm Grading, Neoplasm Staging, Prostate-Specific Antigen, Prostatectomy, Prostatic Neoplasms, Radiotherapy, Taxoids, Treatment OutcomeAdded October 17, 2015
19 MeSH Terms
Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Chung CH, Aulino J, Muldowney NJ, Hatakeyama H, Baumann J, Burkey B, Netterville J, Sinard R, Yarbrough WG, Cmelak AJ, Slebos RJ, Shyr Y, Parker J, Gilbert J, Murphy BA
(2010) Ann Oncol 21
: 864-870MeSH Terms: Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Pharmacological, Boronic Acids, Bortezomib, Carcinoma, Squamous Cell, Docetaxel, Female, Gene Expression Regulation, Neoplastic, Head and Neck Neoplasms, Humans, Male, Middle Aged, NF-kappa B, Neoplasm Metastasis, Pyrazines, Recurrence, Signal Transduction, Survival Analysis, Taxoids, Treatment OutcomeAdded March 5, 2014
20 MeSH Terms
Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, Gilbert J, Chung CH, Murphy BA, Yarbrough WG, Murphy PB, Shyr Y, Cmelak AJ
(2010) Int J Radiat Oncol Biol Phys 77
: 468-76MeSH Terms: Age Factors, Antineoplastic Combined Chemotherapy Protocols, Bridged-Ring Compounds, Carboplatin, Combined Modality Therapy, Dose Fractionation, Radiation, Female, Head and Neck Neoplasms, Humans, Hypothyroidism, Male, Middle Aged, Paclitaxel, Radiation Injuries, Radiography, Radiotherapy, Intensity-Modulated, Retrospective Studies, Risk Factors, Taxoids, Thyroid GlandAdded March 5, 2014
20 MeSH Terms
A spatial model of tumor-host interaction: application of chemotherapy.
Hinow P, Gerlee P, McCawley LJ, Quaranta V, Ciobanu M, Wang S, Graham JM, Ayati BP, Claridge J, Swanson KR, Loveless M, Anderson AR
(2009) Math Biosci Eng 6
: 521-46MeSH Terms: Antineoplastic Agents, Computer Simulation, Docetaxel, Endothelial Cells, Humans, Models, Immunological, Neoplasms, Neovascularization, Pathologic, Taxoids, Vascular Endothelial Growth Factor AAdded February 18, 2013
10 MeSH Terms
Docetaxel in non-small cell lung cancer: impact on quality of life and pharmacoeconomics.
Horn L, Visbal A, Leighl NB
(2007) Drugs Aging 24
: 411-28MeSH Terms: Aged, Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung, Clinical Trials as Topic, Docetaxel, Drug Costs, Humans, Lung Neoplasms, Quality of Life, Taxoids, Treatment OutcomeAdded June 26, 2014
11 MeSH Terms
A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.
Willey CD, Murphy BA, Netterville JL, Burkey BB, Shyr Y, Shakhtour B, Kish B, Raben D, Chen C, Song JI, Kane MA, Cmelak AJ
(2007) Int J Radiat Oncol Biol Phys 67
: 1323-31MeSH Terms: Adult, Aged, Antineoplastic Agents, Combined Modality Therapy, Disease-Free Survival, Docetaxel, Dose Fractionation, Radiation, Erythropoietin, Female, Head and Neck Neoplasms, Hemoglobin A, Humans, Male, Middle Aged, Mouth Mucosa, Prospective Studies, Radiation Injuries, Radiation-Sensitizing Agents, Radiotherapy Dosage, Stomatitis, TaxoidsAdded March 5, 2014
21 MeSH Terms
Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma.
Pipas JM, Barth RJ, Zaki B, Tsapakos MJ, Suriawinata AA, Bettmann MA, Cates JM, Ripple GH, Sutton JE, Gordon SR, McDonnell CE, Perez RP, Redfield N, Meyer LP, Marshall JF, Cole BF, Colacchio TA
(2005) Ann Surg Oncol 12
: 995-1004MeSH Terms: Adenocarcinoma, Adult, Aged, Aged, 80 and over, Antimetabolites, Antineoplastic, Antineoplastic Combined Chemotherapy Protocols, Deoxycytidine, Docetaxel, Humans, Middle Aged, Neoadjuvant Therapy, Pancreatic Neoplasms, Radiotherapy, Conformal, TaxoidsAdded March 15, 2013
14 MeSH Terms
The INPHARMA method: protein-mediated interligand NOEs for pharmacophore mapping.
Sánchez-Pedregal VM, Reese M, Meiler J, Blommers MJ, Griesinger C, Carlomagno T
(2005) Angew Chem Int Ed Engl 44
: 4172-5MeSH Terms: Alkaloids, Epothilones, Ligands, Magnetic Resonance Spectroscopy, Molecular Structure, Proteins, TaxoidsAdded January 24, 2015
7 MeSH Terms